These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007 [TBL] [Abstract][Full Text] [Related]
7. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype. Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856 [TBL] [Abstract][Full Text] [Related]
8. Clinical utility of serological markers in inflammatory bowel disease. Mokrowiecka A; Daniel P; Słomka M; Majak P; Malecka-Panas E Hepatogastroenterology; 2009; 56(89):162-6. PubMed ID: 19453050 [TBL] [Abstract][Full Text] [Related]
9. pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease. Mokrowiecka A; Gasiorowska A; Malecka-Panas E Hepatogastroenterology; 2007; 54(77):1443-8. PubMed ID: 17708273 [TBL] [Abstract][Full Text] [Related]
10. The prevalence and diagnostic value of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease in mainland China. Zhou F; Xia B; Wang F; Shrestha UK; Chen M; Wang H; Shi X; Chen Z; Li J Clin Chim Acta; 2010 Oct; 411(19-20):1461-5. PubMed ID: 20570669 [TBL] [Abstract][Full Text] [Related]
11. [Interest of serologic markers in inflammatory bowel disease. About 105 cases]. Fekih M; Ben Hlima S; Zitouni M; Matri S; Boubaker J; Makni S; Azza F Tunis Med; 2007 Oct; 85(10):821-8. PubMed ID: 18236802 [TBL] [Abstract][Full Text] [Related]
12. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens. Sugi K; Saitoh O; Matsuse R; Tabata K; Uchida K; Kojima K; Nakagawa K; Tanaka S; Teranishi T; Hirata I; Katsu K Am J Gastroenterol; 1999 May; 94(5):1304-12. PubMed ID: 10235211 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Reese GE; Constantinides VA; Simillis C; Darzi AW; Orchard TR; Fazio VW; Tekkis PP Am J Gastroenterol; 2006 Oct; 101(10):2410-22. PubMed ID: 16952282 [TBL] [Abstract][Full Text] [Related]
14. [Initial experience with detection of Saccharomyces cerevisiae antibodies in patients with primary nonspecific inflammatory bowel disease]. Malícková K; Janatková I; Fucíková T; Adamec S; Lukás M Epidemiol Mikrobiol Imunol; 2001 Aug; 50(3):131-5. PubMed ID: 11550421 [TBL] [Abstract][Full Text] [Related]
15. [p-ANCA and ASCA antibodies in the differential diagnosis between ulcerative rectocolitis and Crohn's disease]. Lecis P; Germanà B; Papa N; Bertiato G; Doglioni C; Galliani E; Biedo FC Recenti Prog Med; 2002 May; 93(5):308-13. PubMed ID: 12050913 [TBL] [Abstract][Full Text] [Related]
16. [Diagnostic role of anti-saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease]. Gao X; Hu PJ; He Y; Liao SY; Peng S; Chen MH Zhonghua Nei Ke Za Zhi; 2005 Jun; 44(6):428-30. PubMed ID: 16008854 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Bansi DS; Chapman RW; Fleming KA Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):881-5. PubMed ID: 8889455 [TBL] [Abstract][Full Text] [Related]